经导管卵圆孔未闭封堵术后远期房颤或房扑风险:丹麦全国性研究
该丹麦全国性队列研究纳入2008-2020年817例卵圆孔未闭(PFO)封堵患者、1224例PFO诊断未封堵患者及8170例年龄性别匹配的普通人群,评估封堵术后远期房颤或房扑(AF)风险。结果显示封堵组5年AF风险为7.8%,高于PFO诊断组的3.1%和匹配人群的1.2%;封堵后3个月内AF风险显著升高(HR 2.3 vs PFO诊断组;HR 51 vs 匹配人群),但3个月后风险无显著增加(HR 0.7 vs PFO诊断组;HR 2.5 vs 匹配人群)。结论认为PFO封堵除已知的短期手术相关风险外,不增加远期AF风险。
要点
- PFO封堵术后3个月内AF风险显著升高,与手术相关。
- 封堵术后3个月后AF风险无显著额外增加。
- 封堵组5年AF绝对风险为7.8%,需关注长期监测。
核心结论
- PFO封堵除已知的短期手术相关AF风险外,不增加远期AF风险。
研究设计与样本
- 丹麦全国性队列研究,纳入2008-2020年817例PFO封堵患者、1224例PFO诊断未封堵患者及8170例年龄性别匹配的普通人群对照。
主要发现
- 封堵组5年AF风险为7.8%(95%CI 5.5-10),PFO诊断组为3.1%(95%CI 2.0-4.2),匹配人群为1.2%(95%CI 0.8-1.6)。
- 封堵 vs PFO诊断组:3个月内AF的HR为2.3(95%CI 1.3-4.0),3个月后HR为0.7(95%CI 0.3-1.7)。
- 封堵 vs 匹配人群:3个月内AF的HR为51(95%CI 21-125),3个月后HR为2.5(95%CI 1.2-5.0)。
临床怎么用
- PFO封堵术后应重点关注术后3个月内的AF筛查与监测。
- 术后3个月后AF风险相对稳定,但仍需结合患者个体情况长期随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Transcatheter closure of patent foramen ovale (PFO) is the recommended stroke prevention treatment in patients ≤60 years with cryptogenic ischemic stroke and PFO. Atrial fibrillation or flutter (AF) is a known potential procedure-related complication, but long-term risk of developing AF remains unknown. This paper studied the long-term risk of developing AF following PFO closure. METHODS AND RESULTS: A Danish nationwide cohort study was conducted. During 2008-2020, this study identified a PFO closure cohort, a PFO diagnosis cohort without PFO closure, and a general population comparison cohort matched 10:1 to the PFO closure cohort on age and sex. The outcome was first-time AF diagnosis. Risk of AF and multivariable-adjusted hazard ratio (HR) of the association between PFO closure or PFO diagnosis and AF were calculated. A total of 817 patients with PFO closure, 1224 with PFO diagnosis, and 8170 matched individuals were identified. The 5 year risk of AF was 7.8% [95% confidence interval (CI): 5.5-10] in the PFO closure cohort, 3.1% (95% CI: 2.0-4.2) in the PFO diagnosis cohort, and 1.2% (95% CI: 0.8-1.6) in the matched cohort. The HR of AF comparing PFO closure with PFO diagnosis was 2.3 (95% CI: 1.3-4.0) within the first 3 months and 0.7 (95% CI: 0.3-1.7) thereafter. The HR of AF comparing PFO closure with the matched cohort was 51 (95% CI: 21-125) within the first 3 months and 2.5 (95% CI: 1.2-5.0) thereafter. CONCLUSION: Patent foramen ovale closure was not associated with any substantial increased long-term risk of developing AF beyond the well-known procedure-related short-term risk.
引用
- Skibsted, Korsholm, Pedersen, et al. Long-term risk of atrial fibrillation or flutter after transcatheter patent foramen ovale closure: a nationwide Danish study. Eur Heart J. 2023. PMID: 37279491. doi:10.1093/eurheartj/ehad305
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。